CN108004260A - 调节动物肠道菌群结构的方法 - Google Patents
调节动物肠道菌群结构的方法 Download PDFInfo
- Publication number
- CN108004260A CN108004260A CN201610976999.2A CN201610976999A CN108004260A CN 108004260 A CN108004260 A CN 108004260A CN 201610976999 A CN201610976999 A CN 201610976999A CN 108004260 A CN108004260 A CN 108004260A
- Authority
- CN
- China
- Prior art keywords
- gene
- butyric acid
- animal
- seq
- genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 56
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000000813 microbial effect Effects 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 64
- 230000014509 gene expression Effects 0.000 claims abstract description 32
- 230000000968 intestinal effect Effects 0.000 claims abstract description 31
- 244000005709 gut microbiome Species 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims description 94
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 84
- 230000015572 biosynthetic process Effects 0.000 claims description 34
- 238000003786 synthesis reaction Methods 0.000 claims description 34
- 101150044508 key gene Proteins 0.000 claims description 32
- 239000002775 capsule Substances 0.000 claims description 31
- 230000000692 anti-sense effect Effects 0.000 claims description 28
- 241000588724 Escherichia coli Species 0.000 claims description 24
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 claims description 19
- 101150085857 rpo2 gene Proteins 0.000 claims description 19
- 101150090202 rpoB gene Proteins 0.000 claims description 19
- 101150026435 astA gene Proteins 0.000 claims description 14
- 101150091634 bcd gene Proteins 0.000 claims description 14
- 101150054092 buk gene Proteins 0.000 claims description 14
- 101710084578 Short neurotoxin 1 Proteins 0.000 claims description 13
- 101710182532 Toxin a Proteins 0.000 claims description 13
- 101710112752 Cytotoxin Proteins 0.000 claims description 11
- 101100043145 Cupriavidus necator (strain ATCC 43291 / DSM 13513 / CCUG 52238 / LMG 8453 / N-1) acd gene Proteins 0.000 claims description 10
- 101150031417 buk1 gene Proteins 0.000 claims description 10
- 239000013612 plasmid Substances 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 241001515965 unidentified phage Species 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 7
- 241001132374 Asta Species 0.000 claims description 6
- 238000013519 translation Methods 0.000 claims description 6
- 231100000599 cytotoxic agent Toxicity 0.000 claims description 5
- 239000002619 cytotoxin Substances 0.000 claims description 5
- 230000001988 toxicity Effects 0.000 claims description 5
- 231100000419 toxicity Toxicity 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 101150063145 atoA gene Proteins 0.000 claims description 2
- 101150008413 atoD gene Proteins 0.000 claims description 2
- 230000014616 translation Effects 0.000 claims 3
- -1 but Proteins 0.000 claims 1
- 230000033228 biological regulation Effects 0.000 abstract description 9
- 244000005700 microbiome Species 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 238000010171 animal model Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 241000193468 Clostridium perfringens Species 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 108700005078 Synthetic Genes Proteins 0.000 description 4
- 230000002550 fecal effect Effects 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 108010062877 Bacteriocins Proteins 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 241000588921 Enterobacteriaceae Species 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000011740 C57BL/6 mouse Methods 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 101150052992 PTBP1 gene Proteins 0.000 description 2
- 108020004417 Untranslated RNA Proteins 0.000 description 2
- 102000039634 Untranslated RNA Human genes 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000013412 genome amplification Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 101150048333 ptb gene Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 229940126586 small molecule drug Drugs 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000009777 vacuum freeze-drying Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001176105 Bacteroides fragilis YCH46 Species 0.000 description 1
- 241000304137 Bacteroides thetaiotaomicron VPI-5482 Species 0.000 description 1
- 241000073659 Bacteroides vulgatus ATCC 8482 Species 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 241000423301 Clostridioides difficile 630 Species 0.000 description 1
- 241000987364 Clostridium botulinum A str. ATCC 3502 Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 241000605758 Desulfovibrio vulgaris str. Hildenborough Species 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 241001640759 Escherichia coli O44:H18 Species 0.000 description 1
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 description 1
- 244000185256 Lactobacillus plantarum WCFS1 Species 0.000 description 1
- 235000011227 Lactobacillus plantarum WCFS1 Nutrition 0.000 description 1
- 206010068052 Mosaicism Diseases 0.000 description 1
- 241000073661 Parabacteroides distasonis ATCC 8503 Species 0.000 description 1
- 241000485655 Prevotella melaninogenica ATCC 25845 Species 0.000 description 1
- 101150014221 Son gene Proteins 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003765 sex chromosome Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/08—Oxidoreductases acting on the CH-CH group of donors (1.3) with flavin as acceptor (1.3.8)
- C12Y103/08001—Butyryl-CoA dehydrogenase (1.3.8.1), i.e. short chain acyl-CoA dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01019—Phosphate butyryltransferase (2.3.1.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/02—Phosphotransferases with a carboxy group as acceptor (2.7.2)
- C12Y207/02007—Butyrate kinase (2.7.2.7)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/60—Vectors containing traps for, e.g. exons, promoters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610976999.2A CN108004260B (zh) | 2016-10-28 | 2016-10-28 | 调节动物肠道菌群结构的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610976999.2A CN108004260B (zh) | 2016-10-28 | 2016-10-28 | 调节动物肠道菌群结构的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108004260A true CN108004260A (zh) | 2018-05-08 |
CN108004260B CN108004260B (zh) | 2021-07-06 |
Family
ID=62048468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610976999.2A Active CN108004260B (zh) | 2016-10-28 | 2016-10-28 | 调节动物肠道菌群结构的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108004260B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109234397A (zh) * | 2018-10-16 | 2019-01-18 | 中国药科大学 | 用于检测丁酸合成基因的引物对及试剂盒 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1407108A (zh) * | 2001-09-06 | 2003-04-02 | 胡放 | 表达乳铁蛋白的基因工程重组菌株及其应用 |
CN101627109A (zh) * | 2006-12-01 | 2010-01-13 | 格沃股份有限公司 | 用于生产正丁醇的工程化改造的微生物及相关方法 |
-
2016
- 2016-10-28 CN CN201610976999.2A patent/CN108004260B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1407108A (zh) * | 2001-09-06 | 2003-04-02 | 胡放 | 表达乳铁蛋白的基因工程重组菌株及其应用 |
CN101627109A (zh) * | 2006-12-01 | 2010-01-13 | 格沃股份有限公司 | 用于生产正丁醇的工程化改造的微生物及相关方法 |
Non-Patent Citations (3)
Title |
---|
CURT R. FISCHER等: "Assessment of heterologous butyrate and butanol pathway activity by measurement of intracellular pathway intermediates in recombinant Escherichia coli", 《APPLIED MICROBIAL AND CELL PHYSIOLOGY》 * |
秦环龙: "《肠屏障功能的基础与临床》", 31 July 2007, 上海交通大学出版社 * |
罗云波等: "《食品生物技术导论 第3版》", 31 August 2016, 中国农业大学出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109234397A (zh) * | 2018-10-16 | 2019-01-18 | 中国药科大学 | 用于检测丁酸合成基因的引物对及试剂盒 |
CN109234397B (zh) * | 2018-10-16 | 2021-06-22 | 中国药科大学 | 用于检测丁酸合成基因的引物对及试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN108004260B (zh) | 2021-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | A critical review of antibiotic resistance in probiotic bacteria | |
EP3639834B1 (en) | Use of microbial communities for human and animal health | |
KR101473058B1 (ko) | 과민성 대장 증후군 예방 또는 치료용 조성물 | |
De Vries et al. | Lactobacillus plantarum—survival, functional and potential probiotic properties in the human intestinal tract | |
KR101683474B1 (ko) | 과민성 대장 증후군 예방 또는 치료용 조성물 | |
Hart et al. | Use of probiotics in the treatment of inflammatory bowel disease | |
Cronin et al. | Progress in genomics, metabolism and biotechnology of bifidobacteria | |
Arellano et al. | Safety evaluation and whole-genome annotation of Lactobacillus plantarum strains from different sources with special focus on isolates from green tea | |
Tajabadi et al. | Identification of Lactobacillus plantarum, Lactobacillus pentosus and Lactobacillus fermentum from honey stomach of honeybee | |
CN114317320B (zh) | 一种短双歧杆菌207-1及其应用 | |
BR112012011315B1 (pt) | Formulação que compreende cepa de bifidobactéria probiótica | |
CN104232544A (zh) | 来自完全以母乳喂养的婴儿粪便的具有益生活性的菌株的分离、鉴定和表征 | |
Mahasneh et al. | Probiotics and traditional fermented foods: The eternal connection (Mini-Review) | |
KR102332867B1 (ko) | 유산균, 그 유산균 유래의 자연 면역 활성화제, 감염증 예방 치료제 및 음식품 | |
WO2019227418A1 (zh) | 一种组合物及其应用 | |
Quilodrán-Vega et al. | Isolation of lactic acid bacteria from swine milk and characterization of potential probiotic strains with antagonistic effects against swine-associated gastrointestinal pathogens | |
Gotteland et al. | Probiotic screening and safety evaluation of Lactobacillus strains from plants, artisanal goat cheese, human stools, and breast milk | |
Adam et al. | Probiotics: Recent understandings and biomedical applications | |
Scarpellini et al. | Probiotics: which and when? | |
JP2023033532A (ja) | 骨格筋遅筋化用組成物 | |
JP6214162B2 (ja) | 新規の低温耐性ラクトバチルス・ガセリ株 | |
Xu et al. | Lactobacillus casei JY300-8 generated by 12C6+ beams mutagenesis inhibits tumor progression by modulating the gut microbiota in mice | |
Gayathri et al. | Lactobacillus sp. as probiotics for human health with special emphasis on colorectal cancer | |
CN108004260A (zh) | 调节动物肠道菌群结构的方法 | |
Yepez et al. | Genetic diversity of lactic acid bacteria strains towards their potential probiotic application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 518083 comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, Shenzhen Applicant after: BGI SHENZHEN Address before: 518083 comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, Shenzhen Applicant before: BGI SHENZHEN |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240325 Address after: Building 1-2, Phase 3.1, Wuhan Optics Valley International Biopharmaceutical Enterprise Accelerator, No. 388 Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430223 Patentee after: Wuhan Huada Institute of Life Sciences Country or region after: China Address before: 518083 comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, Shenzhen Patentee before: BGI SHENZHEN Country or region before: China |